China Pharma Holdings (CPHI) Narrows Q2 Loss
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of ($0.09), versus ($0.20) reported last year. Revenue for the quarter came in at $5.7 million, versus $6.1 million reported last year.
For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
- Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
